UBS Group AG - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$875,124
-36.5%
287,870
-31.3%
0.00%
Q2 2023$1,379,125
-20.7%
419,187
-23.3%
0.00%
-100.0%
Q1 2023$1,738,330
-63.1%
546,645
-19.8%
0.00%
-50.0%
Q4 2022$4,716,762
+437.8%
681,613
+392.7%
0.00%
Q3 2022$877,000
+7208.3%
138,349
+4839.3%
0.00%
Q2 2022$12,000
-99.7%
2,801
-99.7%
0.00%
-100.0%
Q1 2022$3,979,000
+0.7%
820,450
+107.5%
0.00%0.0%
Q4 2021$3,950,000
+8.9%
395,413
+108.3%
0.00%0.0%
Q3 2021$3,627,000
+778.2%
189,811
+1366.5%
0.00%
Q2 2021$413,000
-80.7%
12,943
-81.8%
0.00%
-100.0%
Q1 2021$2,141,000
+30.5%
71,017
+87.3%
0.00%
Q4 2020$1,640,000
-33.4%
37,909
-16.9%
0.00%
-100.0%
Q3 2020$2,461,000
-7.6%
45,611
+4.6%
0.00%0.0%
Q2 2020$2,662,000
+74.7%
43,610
+31.5%
0.00%0.0%
Q1 2020$1,524,000
-32.4%
33,154
+29.1%
0.00%
Q4 2019$2,254,000
-66.4%
25,684
-64.8%
0.00%
-100.0%
Q3 2019$6,707,000
+29.0%
73,045
+78.7%
0.00%
+50.0%
Q2 2019$5,198,000
-21.8%
40,870
-3.3%
0.00%
-33.3%
Q1 2019$6,647,000
-27.4%
42,247
-54.2%
0.00%
-25.0%
Q4 2018$9,150,000
+47.0%
92,238
+116.4%
0.00%
+100.0%
Q3 2018$6,224,000
-26.2%
42,629
-20.7%
0.00%
-50.0%
Q2 2018$8,438,000
-7.0%
53,763
+1.2%
0.00%0.0%
Q1 2018$9,073,000
+57.2%
53,134
+63.9%
0.00%
+100.0%
Q4 2017$5,772,000
-19.8%
32,411
-38.2%
0.00%
-33.3%
Q3 2017$7,201,000
+140.6%
52,427
+84.0%
0.00%
+50.0%
Q2 2017$2,993,000
+440.3%
28,492
+367.2%
0.00%
Q1 2017$554,000
-80.5%
6,099
-86.8%
0.00%
-100.0%
Q4 2016$2,848,000
+70.6%
46,170
+87.5%
0.00%
+100.0%
Q3 2016$1,669,000
+447.2%
24,630
+249.6%
0.00%
Q2 2016$305,000
-92.6%
7,045
-92.7%
0.00%
-100.0%
Q1 2016$4,118,000
-56.0%
96,889
-33.6%
0.00%
-50.0%
Q4 2015$9,369,000
+2089.0%
145,883
+2822.3%
0.01%
Q3 2015$428,000
-85.4%
4,992
-71.3%
0.00%
-100.0%
Q2 2015$2,929,000
-29.2%
17,394
-49.2%
0.00%
-33.3%
Q1 2015$4,137,000
-45.0%
34,260
-58.2%
0.00%
-40.0%
Q4 2014$7,525,00082,0390.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders